BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31410964)

  • 21. HMW and LMW kininogens.
    Kato H; Nagasawa S; Iwanaga S
    Methods Enzymol; 1981; 80 Pt C():172-98. PubMed ID: 7043190
    [No Abstract]   [Full Text] [Related]  

  • 22. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
    Thompson RE; Mandle R; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.
    Herwald H; Hock H; Jahnen-Dechent W; Müller-Esterl W
    Agents Actions Suppl; 1992; 38 ( Pt 1)():225-32. PubMed ID: 1466274
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
    Iwaki T; Castellino FJ
    Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory mechanisms of the plasma contact system.
    Maas C; Renné T
    Thromb Res; 2012 May; 129 Suppl 2():S73-6. PubMed ID: 22398015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
    Baglia FA; Walsh PN
    Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contact phase of blood coagulation is not activated in edema of high altitude.
    Bärtsch P; Lämmle B; Huber I; Haeberli A; Vock P; Oelz O; Straub PW
    J Appl Physiol (1985); 1989 Oct; 67(4):1336-40. PubMed ID: 2793733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock.
    Hack CE; Wagstaff J; Strack van Schijndel RJ; Eerenberg AJ; Pinedo HM; Thijs LG; Nuijens JH
    Thromb Haemost; 1991 May; 65(5):497-503. PubMed ID: 1871710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of the participation of the contact system in the Vroman effect. Review and summary.
    Scott CF
    J Biomater Sci Polym Ed; 1991; 2(3):173-81. PubMed ID: 1854683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII.
    Fossum S; Hoem NO; Johannesen S; Korpberget M; Nylund E; Sandem S; Briseid K
    Thromb Res; 1994 Jun; 74(5):477-85. PubMed ID: 8085248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologic activities of the contact activation system.
    Schmaier AH
    Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structures of factor XI and prekallikrein bound to domain 6 of high-molecular weight kininogen reveal alternate domain 6 conformations and exosites.
    Li C; Barroeta AB; Wong SS; Kim HJ; Pathak M; Dreveny I; Meijers JCM; Emsley J
    J Thromb Haemost; 2023 Sep; 21(9):2378-2389. PubMed ID: 37068593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the contact system in ascites from patients with gastrointestinal cancer.
    Buø L; Karlsrud TS; Johansen HT; Aasen AO
    Agents Actions Suppl; 1992; 38 ( Pt 2)():237-48. PubMed ID: 1281373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel family of insect salivary inhibitors blocks contact pathway activation by binding to polyphosphate, heparin, and dextran sulfate.
    Alvarenga PH; Xu X; Oliveira F; Chagas AC; Nascimento CR; Francischetti IM; Juliano MA; Juliano L; Scharfstein J; Valenzuela JG; Ribeiro JM; Andersen JF
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2759-70. PubMed ID: 24092749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
    Mandle RJ; Kaplan AP
    Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
    Mutch NJ; Waters EK; Morrissey JH
    J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.